Zyprexa documents ppt 1.
description
Transcript of Zyprexa documents ppt 1.
![Page 1: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/1.jpg)
Zyprexa documents ppt 1.
This powerpoint has a selection of pages from documents to do with
marketing issues.
![Page 2: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/2.jpg)
What are the “Zyprexa Documents”• Class action court case v Eli-Lilly re alleged with-
holding of ADEs data (wght gain and diabetes) and off-label marketing (dementia and subsyndromal mood swings).
• Subpoenaed internal company documents.• Lawyer (Gottstein), public health physician expert
witness (Egilman), New York Times journalist (Berenson) December 2006.
• 358 files, copious data re int memos, powerpoint pres, marketing strategies…
• Website www.furiousseasons.com (Dawdy) and a German website.
• Judge ordered cannot be retrieved from internet.
![Page 3: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/3.jpg)
What are the “Zyprexa Documents”
• Heavily downloaded from furiousseasons.com• Form basis of journalist articles and web-blog
analyses.• Paper for academic literature (Spielmans)
• Provide insight into the goals and functioning of a big pharmaceutical company.
![Page 4: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/4.jpg)
Issues raised
• Marketing for “NCE’s” (New Clinical Entities) and off-label indications.– Alternatively described as “Disease Mongering” to
increase sales.• Damage control, use of “spin”, possible
concealment re ADEs.• Sophistication of pharma companies in
interacting with (controlling?) “customers”.= physicians, pharmacists, hospitals/govt, allied health,
patient advocacy groups.
![Page 5: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/5.jpg)
ZY100035541 Olanzapine Lifeplan
• The “Safer Clozapine”• Market is
Schizophrenia.• No mention of bipolar
or dementia.
![Page 6: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/6.jpg)
ZY100035541 Olanzapine Lifeplan
![Page 7: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/7.jpg)
ZY100035541 Olanzapine Lifeplan
• The “Safer Clozapine”
• Market is Schizophrenia.
• No mention of bipolar or dementia.
![Page 8: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/8.jpg)
ZY100035541 Olanzapine Lifeplan
![Page 9: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/9.jpg)
ZY201548768 Betting the Farm
• Prozac patent due to expire August 2001.
![Page 10: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/10.jpg)
ZY201548768 Betting the Farm
![Page 11: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/11.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 12: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/12.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 13: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/13.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 14: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/14.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 15: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/15.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 16: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/16.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 17: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/17.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 18: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/18.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 19: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/19.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 20: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/20.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 21: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/21.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 22: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/22.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 23: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/23.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 24: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/24.jpg)
ZY200270343 Zyprexa Product Team summary 1997
![Page 25: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/25.jpg)
ZY100041262 PCP opportunity
![Page 26: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/26.jpg)
ZY100041262 PCP opportunity
![Page 27: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/27.jpg)
ZY100041262 PCP opportunity
![Page 28: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/28.jpg)
ZY100520662 Zyprexa primary care briefing document 21July2000
![Page 29: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/29.jpg)
ZY100520662 Zyprexa primary care briefing document 21July2000
![Page 30: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/30.jpg)
ZY100520662 Zyprexa primary care briefing document 21July2000
![Page 31: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/31.jpg)
ZY100520662 Zyprexa primary care briefing document 21July2000
![Page 32: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/32.jpg)
ZY100520662 Zyprexa primary care briefing document 21July2000
![Page 33: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/33.jpg)
ZY100582035 Zyprexa Complicated Mood Project date?
![Page 34: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/34.jpg)
ZY201797499 email re driving depression story since 98 Feb 2000
![Page 35: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/35.jpg)
![Page 36: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/36.jpg)
ZY200083405 PCP vision
![Page 37: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/37.jpg)
ZY200083405 PCP vision
![Page 38: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/38.jpg)
ZY200083405 PCP vision
![Page 39: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/39.jpg)
ZY200083405 PCP vision
![Page 40: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/40.jpg)
ZY200083405 PCP vision
![Page 41: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/41.jpg)
ZY100040886 Primary Care Physician strategy
![Page 42: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/42.jpg)
ZY100040886 Primary Care Physician strategy
![Page 43: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/43.jpg)
ZY100040886 Primary Care Physician strategy
![Page 44: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/44.jpg)
ZY100040886 Primary Care Physician strategy
![Page 45: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/45.jpg)
ZY200083622 Addressing PCP FAOC
![Page 46: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/46.jpg)
ZY200083622 Addressing PCP FAOC
![Page 47: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/47.jpg)
ZY200083622 Addressing PCP FAOC
![Page 48: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/48.jpg)
ZY200083622 Addressing PCP FAOC
![Page 49: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/49.jpg)
ZY 100175096Viva Zyprexa
![Page 50: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/50.jpg)
ZY 100175096 Viva ZyprexaPCPs/GPs = financial opportunities
![Page 51: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/51.jpg)
ZY 100175096 Viva ZyprexaUnmet needs/disease-mongering
![Page 52: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/52.jpg)
ZY 100175096 Viva ZyprexaUnmet needs/disease-mongering
![Page 53: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/53.jpg)
ZY 100175096 Viva ZyprexaUnmet needs/disease-mongering
![Page 54: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/54.jpg)
ZY 100175096 Viva ZyprexaUnmet needs/disease-mongering
![Page 55: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/55.jpg)
ZY 100175096 Viva ZyprexaIncentives to sales reps
![Page 56: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/56.jpg)
ZY 100175096 Viva ZyprexaPhysician type casting & targeting
![Page 57: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/57.jpg)
ZY 100175096 Viva ZyprexaPhysician CME strategy
![Page 58: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/58.jpg)
ZY 100175096 Viva ZyprexaHave the “customers” got the message?
![Page 59: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/59.jpg)
ZY 100175096 Viva Zyprexastudying and utilising the “customers”
![Page 60: Zyprexa documents ppt 1.](https://reader035.fdocuments.us/reader035/viewer/2022062323/56815bd4550346895dc9c4be/html5/thumbnails/60.jpg)
ZY 100175096 Viva Zyprexa
To the tune of “Viva Las
Vegas”